A revolutionary perspective

The stem cells used by Osiris Therapeutics, Inc. represent a platform technology. These cells have demonstrated anti-inflammatory properties and that they can prevent scar tissue formation and regenerate specific tissue structures, making them potentially useful in a wide range of conditions.

Providing regenerative treatments

Take a closer look at why Osiris Therapeutics is on the verge of revolutionizing the practice of medicine. Read more.

Adult immune privileged mesenchymal stem cells for use in clinical trial patients unrelated to the donor:

Osiris was founded in 1992 to develop Dr. Arnold Caplan and his colleagues' innovative technology for isolating and expanding mesenchymal stem cells (MSC) derived from donated bone marrow for therapeutic drug products.